Antibiotic TPU-0037-C (CAS 485815-61-0)

Antibiotic TPU-0037-C, a member of the thiomuracin family isolated from a marine-derived Streptomyces species, has emerged as a significant compound in research due to its potent antibacterial activity and unique mechanism of action. This compound exerts its bactericidal effects by inhibiting bacterial RNA polymerase, the enzyme responsible for transcription initiation and elongation. Through its interaction with the RNA polymerase, Antibiotic TPU-0037-C disrupts the transcription process, leading to the inhibition of bacterial RNA synthesis and ultimately bacterial cell death. Research has focused on elucidating the structural features of Antibiotic TPU-0037-C and its binding interactions with bacterial RNA polymerase, providing insights into its mechanism of action and potential for structure-based drug design. Additionally, studies have explored its efficacy against various bacterial pathogens, including both Gram-positive and Gram-negative species, highlighting its broad-spectrum antimicrobial activity. Furthermore, Antibiotic TPU-0037-C has served as a valuable tool in microbial biology research, facilitating the study of transcriptional regulation and bacterial gene expression. Overall, Antibiotic TPU-0037-C represents a promising candidate for further exploration in antibacterial drug discovery and as a tool for investigating bacterial transcriptional machinery.